1
|
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.
|
Pharmacol Rev
|
2009
|
3.65
|
2
|
Formyl-peptide receptors revisited.
|
Trends Immunol
|
2002
|
3.08
|
3
|
Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo.
|
Nature
|
2013
|
2.19
|
4
|
Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87.
|
Cancer Lett
|
2008
|
1.93
|
5
|
A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1.
|
Proc Natl Acad Sci U S A
|
2005
|
1.82
|
6
|
Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
|
Neurosurgery
|
2007
|
1.79
|
7
|
Toll-like receptors in inflammation, infection and cancer.
|
Int Immunopharmacol
|
2007
|
1.76
|
8
|
Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells.
|
J Virol
|
2002
|
1.64
|
9
|
Resveratrol differentially modulates inflammatory responses of microglia and astrocytes.
|
J Neuroinflammation
|
2010
|
1.41
|
10
|
Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide.
|
J Biol Chem
|
2005
|
1.39
|
11
|
Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor.
|
J Immunol
|
2004
|
1.35
|
12
|
G protein-coupled receptors serve as mechanosensors for fluid shear stress in neutrophils.
|
Am J Physiol Cell Physiol
|
2006
|
1.29
|
13
|
Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease.
|
J Leukoc Biol
|
2002
|
1.26
|
14
|
A critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses.
|
J Immunol
|
2010
|
1.26
|
15
|
Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose.
|
J Immunol
|
2004
|
1.22
|
16
|
Ceramide, a target for antiretroviral therapy.
|
Proc Natl Acad Sci U S A
|
2004
|
1.22
|
17
|
Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia.
|
Int Immunopharmacol
|
2005
|
1.21
|
18
|
Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
|
J Natl Cancer Inst
|
2005
|
1.21
|
19
|
Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor.
|
J Immunol
|
2004
|
1.20
|
20
|
Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells.
|
PLoS One
|
2013
|
1.18
|
21
|
Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia.
|
Int Immunopharmacol
|
2006
|
1.13
|
22
|
The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
|
Clin Cancer Res
|
2005
|
1.12
|
23
|
Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells.
|
Cancer Res
|
2007
|
1.10
|
24
|
Receptors for chemotactic formyl peptides as pharmacological targets.
|
Int Immunopharmacol
|
2002
|
1.08
|
25
|
F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor.
|
J Immunol
|
2007
|
1.08
|
26
|
Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma.
|
Mod Pathol
|
2007
|
1.07
|
27
|
CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein- coupled receptor mFPR2.
|
FASEB J
|
2005
|
1.06
|
28
|
CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system.
|
Cell Mol Immunol
|
2006
|
1.05
|
29
|
Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells.
|
PLoS One
|
2013
|
1.05
|
30
|
Homologues of human macrophage migration inhibitory factor from a parasitic nematode. Gene cloning, protein activity, and crystal structure.
|
J Biol Chem
|
2002
|
1.04
|
31
|
High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis.
|
Arterioscler Thromb Vasc Biol
|
2011
|
1.03
|
32
|
Connexin 43 reverses malignant phenotypes of glioma stem cells by modulating E-cadherin.
|
Stem Cells
|
2012
|
1.01
|
33
|
Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells.
|
J Immunol
|
2002
|
1.00
|
34
|
Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease.
|
Immunol Res
|
2005
|
0.99
|
35
|
Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.
|
J Clin Invest
|
2013
|
0.99
|
36
|
Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR.
|
J Neurooncol
|
2007
|
0.99
|
37
|
Formylpeptide receptors are critical for rapid neutrophil mobilization in host defense against Listeria monocytogenes.
|
Sci Rep
|
2012
|
0.98
|
38
|
TGF-beta1 disrupts endotoxin signaling in microglial cells through Smad3 and MAPK pathways.
|
J Immunol
|
2004
|
0.95
|
39
|
Cutting edge: vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors.
|
J Immunol
|
2003
|
0.95
|
40
|
The heavy metal cadmium induces valosin-containing protein (VCP)-mediated aggresome formation.
|
Toxicol Appl Pharmacol
|
2008
|
0.95
|
41
|
The active contribution of Toll-like receptors to allergic airway inflammation.
|
Int Immunopharmacol
|
2011
|
0.95
|
42
|
G-protein coupled chemoattractant receptors and cancer.
|
Front Biosci
|
2008
|
0.94
|
43
|
Induction of the formyl peptide receptor 2 in microglia by IFN-gamma and synergy with CD40 ligand.
|
J Immunol
|
2007
|
0.92
|
44
|
Interleukin 4 induces the apoptosis of mouse microglial cells by a caspase-dependent mechanism.
|
Neurobiol Dis
|
2011
|
0.90
|
45
|
Biologically active peptides interacting with the G protein-coupled formylpeptide receptor.
|
Protein Pept Lett
|
2007
|
0.90
|
46
|
Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis.
|
FEBS J
|
2005
|
0.90
|
47
|
Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling.
|
J Biol Chem
|
2012
|
0.89
|
48
|
Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages.
|
Cancer Res
|
2012
|
0.89
|
49
|
Cooperation between NOD2 and Toll-like receptor 2 ligands in the up-regulation of mouse mFPR2, a G-protein-coupled Abeta42 peptide receptor, in microglial cells.
|
J Leukoc Biol
|
2008
|
0.89
|
50
|
Incorporation of endothelial progenitor cells into the neovasculature of malignant glioma xenograft.
|
J Neurooncol
|
2008
|
0.89
|
51
|
Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells.
|
J Immunol
|
2013
|
0.89
|
52
|
The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR.
|
Int Immunopharmacol
|
2009
|
0.88
|
53
|
Role of the autocrine chemokines MIP-1alpha and MIP-1beta in the metastatic behavior of murine T cell lymphoma.
|
J Leukoc Biol
|
2002
|
0.88
|
54
|
Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.
|
Virology
|
2004
|
0.87
|
55
|
RV09, a novel resveratrol analogue, inhibits NO and TNF-alpha production by LPS-activated microglia.
|
Int Immunopharmacol
|
2008
|
0.87
|
56
|
Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression.
|
Cancer Lett
|
2008
|
0.87
|
57
|
Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion.
|
J Virol
|
2004
|
0.86
|
58
|
The anti-cancer compound Nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells.
|
J Neurooncol
|
2007
|
0.86
|
59
|
Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation.
|
Carcinogenesis
|
2008
|
0.86
|
60
|
Apolipoproteins and apolipoprotein mimetic peptides modulate phagocyte trafficking through chemotactic activity.
|
J Biol Chem
|
2012
|
0.86
|
61
|
IL-4 down-regulates lipopolysaccharide-induced formyl peptide receptor 2 in murine microglial cells by inhibiting the activation of mitogen-activated protein kinases.
|
J Immunol
|
2003
|
0.86
|
62
|
G protein-coupled receptor FPR1 as a pharmacologic target in inflammation and human glioblastoma.
|
Int Immunopharmacol
|
2012
|
0.86
|
63
|
Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1.
|
Am J Pathol
|
2011
|
0.86
|
64
|
IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta1-42, in TNF-alpha-activated microglia.
|
J Immunol
|
2005
|
0.85
|
65
|
Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis.
|
Immunology
|
2014
|
0.85
|
66
|
The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
|
Virol J
|
2006
|
0.85
|
67
|
IL-2 and IL-12 alter NK cell responsiveness to IFN-gamma-inducible protein 10 by down-regulating CXCR3 expression.
|
J Immunol
|
2002
|
0.85
|
68
|
Intracellular cross-talk between the GPCR CXCR1 and CXCR2: role of carboxyl terminus phosphorylation sites.
|
Exp Cell Res
|
2007
|
0.84
|
69
|
Signal relay by CC chemokine receptor 2 (CCR2) and formylpeptide receptor 2 (Fpr2) in the recruitment of monocyte-derived dendritic cells in allergic airway inflammation.
|
J Biol Chem
|
2013
|
0.84
|
70
|
HCV peptide (C5A), an amphipathic α-helical peptide of hepatitis virus C, is an activator of N-formyl peptide receptor in human phagocytes.
|
J Immunol
|
2011
|
0.83
|
71
|
Tumor microvascular architecture phenotype (T-MAP) as a new concept for studies of angiogenesis and oncology.
|
J Neurooncol
|
2006
|
0.83
|
72
|
Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with pneumocystis pneumonia.
|
PLoS Genet
|
2011
|
0.82
|
73
|
The role of dendritic cells in neurodegenerative diseases.
|
Arch Immunol Ther Exp (Warsz)
|
2002
|
0.82
|
74
|
Toll-like receptor 2 ligands promote microglial cell death by inducing autophagy.
|
FASEB J
|
2012
|
0.82
|
75
|
Molecular cloning and functional characterization of porcine nucleotide-binding oligomerization domain-2 (NOD2).
|
Mol Immunol
|
2007
|
0.81
|
76
|
A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression.
|
Cancer Lett
|
2012
|
0.81
|
77
|
Enzymatic digestion of the milk protein beta-casein releases potent chemotactic peptide(s) for monocytes and macrophages.
|
Int Immunopharmacol
|
2007
|
0.80
|
78
|
Synergy of TRIF-dependent TLR3 and MyD88-dependent TLR7 in up-regulating expression of mouse FPR2, a promiscuous G-protein-coupled receptor, in microglial cells.
|
J Neuroimmunol
|
2009
|
0.80
|
79
|
Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas.
|
Int Immunopharmacol
|
2005
|
0.80
|
80
|
Interleukin 10 and TNFalpha synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia.
|
Neurobiol Dis
|
2007
|
0.79
|
81
|
Ectopic ATP synthase facilitates transfer of HIV-1 from antigen-presenting cells to CD4(+) target cells.
|
Blood
|
2012
|
0.79
|
82
|
The immunopharmacological properties of transforming growth factor beta.
|
Int Immunopharmacol
|
2005
|
0.79
|
83
|
Effects of cobalt chloride on nitric oxide and cytokines/chemokines production in microglia.
|
Int Immunopharmacol
|
2012
|
0.79
|
84
|
Silencing the formylpeptide receptor FPR by short-interfering RNA.
|
Mol Pharmacol
|
2004
|
0.79
|
85
|
Unique proteomic features induced by a potential antiglioma agent, Nordy (dl-nordihydroguaiaretic acid), in glioma cells.
|
Proteomics
|
2008
|
0.78
|
86
|
Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells.
|
Int Immunopharmacol
|
2011
|
0.78
|
87
|
RNA interference as a novel and powerful tool in immunopharmacological research.
|
Int Immunopharmacol
|
2007
|
0.78
|
88
|
Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults.
|
Curr Med Chem
|
2016
|
0.77
|
89
|
A novel lipoxygenase inhibitor Nordy attenuates malignant human glioma cell responses to chemotactic and growth stimulating factors.
|
J Neurooncol
|
2007
|
0.77
|
90
|
Transduction of the gene coding for a human G-protein coupled receptor FPRL1 in mouse tumor cells increases host anti-tumor immunity.
|
Int Immunopharmacol
|
2005
|
0.77
|
91
|
The grape component resveratrol interferes with the function of chemoattractant receptors on phagocytic leukocytes.
|
Cell Mol Immunol
|
2004
|
0.76
|
92
|
Proinflammatory stimulants promote the expression of a promiscuous G protein-coupled receptor, mFPR2, in microvascular endothelial cells.
|
Inflammation
|
2012
|
0.76
|
93
|
Manipulating chemoattractant and receptor genes.
|
In Vivo
|
2002
|
0.75
|
94
|
The role of chemokine receptors in the promotion of viral infections.
|
Contrib Microbiol
|
2003
|
0.75
|
95
|
Silencing of ATP4B of ATPase H(+)/K(+) Transporting Beta Subunit by Intragenic Epigenetic Alteration in Human Gastric Cancer Cells.
|
Oncol Res
|
2017
|
0.75
|
96
|
Toll-like receptors and diseases.
|
Int Immunopharmacol
|
2011
|
0.75
|
97
|
Chemoattractants and receptors in Alzheimer's disease.
|
Front Biosci (Schol Ed)
|
2010
|
0.75
|